Fig. 2From: Prime-boost vaccination strategy enhances immunogenicity compared to single pneumococcal conjugate vaccination in patients receiving conventional DMARDs, to some extent in abatacept but not in rituximab-treated patientsThe number of serotypes with positive antibody response after PCV13 and PCV13 + PPV23 in treatment groups and controlsBack to article page